Houston-based University of Texas MD Anderson Cancer Center has partnered with CureVac, a global biopharmaceutical company, to develop novel mRNA-based cancer vaccines.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
MD Anderson partners on mRNA cancer vaccines
